ACVR1B and cancer: In recent years, many studies have demonstrated that the Nodal/ALK4,7/Smad2 pathway is activated in malignant tumors, such as melanoma, breast cancer, endometrial carcinoma, and prostate cancer, and its activation is directly related to an increase in tumor cell plasticity [95,96,97].